A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
Ontology highlight
ABSTRACT: Disseminated tumors cells (DTCs) present in the bone marrow (BM) are believed to be the progenitors of distant metastatic spread, a major cause of mortality in breast cancer patients. To better understand the behavior and therapeutic vulnerabilities of these rare cell populations, unbiased methods for selective cell enrichment are required. In this study, we have evaluated a microfluidic-based filtration system (ParsortixR, Angle PLC), previously demonstrated for use in circulating tumor cell (CTC) capture, to capture BM DTCs. Performance using BM samples was also compared directly to enrichment of CTCs in the peripheral blood (PB) from both metastatic and non-metastatic breast cancer patients. Although the non-specific capture of BM immune cells was significant, the device could routinely
SUBMITTER: Pillai SG
PROVIDER: S-EPMC8121342 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA